Date Initiated by Firm |
March 04, 2011 |
Date Posted |
July 06, 2011 |
Recall Status1 |
Terminated 3 on September 25, 2012 |
Recall Number |
Z-2742-2011 |
Recall Event ID |
58847 |
510(K)Number |
K002177
|
Product Classification |
Hematology Multipurpose System for In Vitro Coagulation Studies - Product Code JPA
|
Product |
TEG Hemostasis System Level II Control: Biological Quality Control Level II Kit for Thrombelastograph Coagulation Analyzer TEG 5000 Series
Used as the operational check and calibration verification for the TEG 5000 Thrombelastograph Hemostasis Analyzer System
|
Code Information |
part number 07-008, catalog number REF 8002, lot numbers HMO196 and HMO197, expiration date July 2011 |
Recalling Firm/ Manufacturer |
Haemoscope Division of Haemonetics Corp 6231 W Howard St Niles IL 60714-3403
|
For Additional Information Contact |
Ms. Susan Finneran 800-438-2834
|
Manufacturer Reason for Recall |
Haemoscope received a report that during the process of Validation, Level II QC was running with an out-of-range low MA (Maximum Amplitude).
|
FDA Determined Cause 2 |
Other |
Action |
Haemoscope, a Division of Haemonetics Corp, sent a letter dated March 2, 2011 to all of the affected customers.
The letters informed the customers that Haemoscope had received a higher than normal inquiry rate for the Level II Quality Control Kits, part 07-008, lots HMO196 and HMO 197. The accounts were requested to return their stocks of those two lots for further testing and evaluation and to complete the enclosed acknowledgement form, confirming receipt of the letter and the number of kit boxes being returned, and fax it back to Haemoscope at 847-588-0455. The returned kits will be replaced at no charge.
For additional information please contact Haemoscope at 847-588-0453, ext-217 . |
Quantity in Commerce |
568 kits |
Distribution |
Worldwide Distribution: (USA) Nationwide and the countries of Canada, Czech Republic and the Philippines |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database |
510(K)s with Product Code = JPA and Original Applicant = HAEMOSCOPE CORP.
|